Search

everythinglearnresearchcommunity

for

Search:↓

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

The study aims to understand how mood, physical activity, light exposure, and seasonal changes affect sleep patterns.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Micrografts are a safe and effective treatment for hair loss in both men and women.

Postmenopausal women with hair loss should get proper tests and consider treatments like minoxidil.

Hospital staff have a higher rate of hair loss than the general population.

Androgenetic alopecia is significantly linked to metabolic syndrome.

Androgenetic alopecia, or hair loss, is most common in people in their 30s, can start early, is often inherited, and may be influenced by factors like hormones and scalp health.

Platelet Rich Plasma (PRP) therapy can improve hair thinning in male pattern baldness patients, but more research is needed to confirm its effectiveness.

Inflammation may play a role in causing androgenetic alopecia.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Low iron levels are linked to hair loss in women.

The document reviews the latest and most effective hair restoration techniques for male and female hair loss.

Hair loss was most commonly due to alopecia areata, androgenetic alopecia, and telogen effluvium, with a higher number of cases in the 1990s and equal occurrence in men and women.

The model accurately simulates human hair growth and hair loss patterns.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

The article concludes that PRP might help with hair loss, but more detailed research is necessary.

Rb-bFGF improves hair transplant results and patient satisfaction with fewer complications.

New understanding and treatments for hair loss are improving, but more research is needed.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

High androgen levels cause skin issues in PCOS, affecting quality of life.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

Low iron levels are significantly linked to hair loss in women.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.